Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines

Journal of Virology

Volumn 74, Issue 5, 2000, Pages 2255-2264

  Mcclary, Heike ^a   Koch, Rick ^a   Chisari, Francis V ^a   Guidotti, Luca G ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; VIRUS DNA; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HEPATITIS B VIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; CYTOKINES; HEPATITIS B; HEPATITIS B VIRUS; INTERFERON INDUCERS; INTERFERON TYPE II; LYMPHOCYTE TRANSFUSION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; POLY I-C; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTES, CYTOTOXIC; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 0033951066     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.5.2255-2264.2000     Document Type: Article

References (23)

1. Ando, K., T. Moriyama, L. G. Guidotti, S. Wirth, R. D. Schreiber, H. J. Schlicht, S. Huang, and F. V. Chisari. 1993. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J. Exp. Med. 178:1541-1554.
2. Beutler, B., D. Greenwald, J. D. Hulmes, M. Chans, Y. C. Pan, J. Mathison, R. Ulevitch, and A. Cerami. 1985. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 316:552-554.
3. Cavanaugh, V. J., L. G. Guidotti, and F. V. Chisari. 1998. Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice. J. Virol. 72:2630-2637.
4. Chisari, F. V., and C. Ferrari. 1995. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13:29-60.
5. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259:1739-1742.
6. Elkon, K. B., C. C. Liu, J. G. Gall, J. Trevejo, M. W. Marino, K. A. Abrahamsen, X. Song, J. L. Zhou, L. J. Old, R. G. Crystal, and E. Falck-Pedersen. 1997. Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors. Proc. Natl. Acad. Sci. USA 94:9814-9819.
7. Guidotti, L. G., P. Borrow, M. V. Hobbs, B. Matzke, I. Gresser, M. B. A. Oldstone, and F. V. Chisari. 1996. Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc. Natl. Acad. Sci. USA 93:4589-4594.
8. Guidotti, L. G., and F. V. Chisari. 1999. Cytokine-induced viral purging -role in viral pathogenesis. Curr. Opin. Microbiol. 2:388-391.
9. Guidotti, L. G., and F. V. Chisari. 1996. To kill or to cure: options in host defense against viral infection. Curr. Opin. Immunol. 8:478-483.
10. Guidotti, L. G., T. Ishikawa, M. V. Hobbs, B. Matzke, R. Schreiber, and F. V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25-36.
11. Guidotti, L. G., B. Matzke, H. Schaller, and F. V. Chisari. 1995. High-level hepatitis B virus replication in transgenic mice. J. Virol. 69:6158-6169.
12. Guidotti, L. G., R. Rochford, L. Chung, M. Shapiro, R. Purcell, and F. V. Chisari. 1999. Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825-829.
13. Kozarsky, K., and J. M. Wilson. 1993. Gene therapy: adenovirus vectors. Curr. Opin. Genet. Dev. 3:499-503.
14. Lampson, G. P., A. A. Tytell, A. K. Field, M. M. Nemes, and M. R. Hilleman. 1967. Inducers of interferon and host resistance, I. Double-stranded RNA from extracts of Penicillium funiculosum. Proc. Natl. Acad. Sci. USA 58: 782-789.
15. Morrey, J. D., and R. W. Sidwell. 1998. Transgenic mice as chemotherapeutic model for hepatitis B virus infection. Antivir. Ther. 3:165-174.
16. Moskophidis, D., M. Battegay, M.-A. Bruendler, E. Laine, I. Gresser, and R. M. Zinkernagel. 1994. Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon. J. Virol. 68:1951-1955.
17. Muller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918-1921.
18. Pfeffer, K., T. Matsuyama, T. M. Kündig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P. S. Ohashi, M. Krönke, and T. W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457-467.
19. Purcell, R. H., W. T. London, V. J. McAuliffe, A. E. Palmer, P. M. Kaplan, J. L. Gerin, J. Wagner, H. Popper, E. Lvovsky, D. C. Wong, and H. B. Levy. 1976). Modification of chronic hepatitis-B virus infection in chimpanzees by administration of an interferon inducer. Lancet ii:757-761.
20. Samuel, C. E., and G. S. Knutson. 1982. Mechanism of interferon action. Kinetics of induction of the antiviral state and protein phosphorylation in mouse fibroblasts treated with natural and cloned interferons. J. Biol. Chem. 257:11791-11795.
21. Shimizu, Y., L. G. Guidotti, P. Fowler, and F. V. Chisari. 1998 Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice. J. Immunol. 161:4520-4529.
22. Weck, P. K., E. Rinderknecht, D. A. Estell, and N. Stebbing. 1982. Antiviral activity of bacteria-derived human alpha interferons against encephalomyocarditis virus infection of mice. Infect. Immun. 35:660-665.
23. Yang, Y., H. C. J. Ertl, and J. M. Wilson. 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1:433-442.